Sangeeta N. Bhatia
Director · VERTEX PHARMACEUTICALS INC / MA
- 2025
- May 5, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sangeeta N. Bhatia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Amit Sachdev - $28.38M in VRTX purchases and sales in the last 12 months
- Reshma Kewalramani - $19.74M in VRTX purchases and sales in the last 12 months
- Carmen Bozic - $11.31M in VRTX purchases and sales in the last 12 months
- Charles F. Wagner Jr. - $6.38M in VRTX purchases and sales in the last 12 months
- Duncan McKechnie - $5.66M in VRTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sangeeta N. Bhatia?
Sangeeta N. Bhatia is a corporate insider, tracked as Director of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sangeeta N. Bhatia last file a Form 4?
The most recent primary Form 4 on record is dated 5 May 2026, one of 3 filings going back to 2025.
Has Sangeeta N. Bhatia been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($371K) across all tracked filings.
